ABBV CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Shareholders of Securities Fraud Class Action Lawsuit Pharmaceutical Investing
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
RINVOQ® Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis Pharmaceutical Investing
ABBV LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving AbbVie Inc. Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Reminds ABBV Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf Pharmaceutical Investing
DEADLINE ALERT for ABBV, MYPS, SDIG, and LICY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Reminds AbbVie, Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
ABBV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 6, 2022 in the Class Action Filed on Behalf of AbbVie Inc. Limited Shareholders Pharmaceutical Investing
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months Pharmaceutical Investing
